Manipulation of the endocannabinoid system by a general anaesthetic

Por Di Marzo, Vincenzo
Publicado em 2003

Endocannabinoids: An appetite for fat

Por Di Marzo, Vincenzo
Publicado em 2011

“Redundancy” of Endocannabinoid Inactivation: New Challenges and Opportunities for Pain Control

Por Piscitelli, Fabiana, Di Marzo, Vincenzo
Publicado em 2012

Fetal cannabinoid receptors and the “dis-joint-ed” brain

Por Cristino, Luigia, Di Marzo, Vincenzo*
Publicado em 2014

The Endocannabinoid System and its Modulation by Phytocannabinoids

Por Di Marzo, Vincenzo, Piscitelli, Fabiana
Publicado no Neurotherapeutics (2015)

The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations

Por Petrosino, Stefania, Di Marzo, Vincenzo
Publicado no Br J Pharmacol (2016)

Placebo Effects in a Multiple Sclerosis Spasticity Enriched Clinical Trial with the Oromucosal Cannabinoid Spray (THC/CBD): Dimension and Possible Causes

Por Di Marzo, Vincenzo, Centonze, Diego
Publicado no CNS Neurosci Ther (2014)

Endocannabinoids in nervous system health and disease: the big picture in a nutshell

Por Skaper, Stephen D., Di Marzo, Vincenzo
Publicado em 2012

Why do cannabinoid receptors have more than one endogenous ligand?

Por Di Marzo, Vincenzo, De Petrocellis, Luciano
Publicado em 2012

v-K-ras leads to preferential farnesylation of p21(ras) in FRTL-5 cells: Multiple interference with the isoprenoid pathway

Por Laezza, Chiara, Di Marzo, Vincenzo, Bifulco, Maurizio
Publicado em 1998

Endocannabinoid signalling and the deteriorating brain

Por Di Marzo, Vincenzo, Stella, Nephi, Zimmer, Andreas
Publicado no Nat Rev Neurosci (2015)

Phytocannabinoids beyond the Cannabis plant – do they exist?

Por Gertsch, Jürg, Pertwee, Roger G, Di Marzo, Vincenzo
Publicado em 2010

Erratum to: Cannabinoids in the Treatment of Neurological Disorders

Por Devinsky, Orrin, Whalley, Benjamin J., Di Marzo, Vincenzo
Publicado no Neurotherapeutics (2015)

Cannabinoids in the Treatment of Neurological Disorders

Por Devinsky, Orrin, Whalley, Benjamin J., Di Marzo, Vincenzo
Publicado no Neurotherapeutics (2015)

Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System

Por McPartland, John M., Guy, Geoffrey W., Di Marzo, Vincenzo
Publicado em 2014

Endocannabinoids Generated by Ca(2+) or by Metabotropic Glutamate Receptors Appear to Arise from Different Pools of Diacylglycerol Lipase

Por Zhang, Longhua, Wang, Meina, Bisogno, Tiziana, Di Marzo, Vincenzo, Alger, Bradley E.
Publicado em 2011

Are cannabidiol and Δ(9)-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

Por McPartland, John M, Duncan, Marnie, Di Marzo, Vincenzo, Pertwee, Roger G
Publicado no Br J Pharmacol (2015)

Endocannabinoid-dependent disinhibition of orexinergic neurons: Electrophysiological evidence in leptin-knockout obese mice

Por Becker, Thorsten Michael, Favero, Morgana, Di Marzo, Vincenzo, Cristino, Luigia, Busetto, Giuseppe
Publicado no Mol Metab (2017)

Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets

Por Berger, Alvin, Crozier, Gayle, Bisogno, Tiziana, Cavaliere, Paolo, Innis, Sheila, Di Marzo, Vincenzo
Publicado em 2001

Evaluation of the endogenous cannabinoid system in mediating the behavioral effects of dipyrone (metamizol) in mice

Por Schlosburg, Joel E., Radanova, Lilyana, Di Marzo, Vincenzo, Imming, Peter, Lichtman, Aron H.
Publicado em 2012